Supplementary Figure 5 from Bicistronic CAR T Cell against BCMA and CD229 Effectively Controls Myeloma Even When BCMA Expression Is Limited
Year: 2025
Type: supplementary-materials
Abstract: Cytokine production (IFNγ and IL-2) of CAR T-cells in co-culture with K562 cell lines with different expression of CD229 antigen tumor cells at the 24-hr time point measured by ELISA.
Authors: Luis Gerardo Rodríguez-Lobato, Oriol Cardús, Joan Mañé-Pujol, Anthony M. Battram, Sergi Vaqué-Salsench, Judith Carpio, Lorena Pérez-Amill, Hugo Calderón, Beatriz Martín-Antonio, Aina Oliver-Caldés, Ester Lozano, David F. Moreno, Valentin Ortiz-Maldonado, Maria Queralt Salas, Anna de Daniel, Natalia Tovar, M. Teresa Cibeira, Laura Rosiñol, Joan Bladé, Manel Juan, Álvaro Urbano-Ispizua, Pablo Engel, Carlos Fernández de Larrea
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4413906970